Analysis of the clinical antibacterial and antituberculosis pipeline

15 Oct 2018

by Theuretzbacher U, Gottwalt S, Beyer P, Butler M, Czaplewski L, Lienhardt C, Moja L, Paul M, Paulin S, Rex JH, Silver LL, Spigelman M, Thwaites GE, Paccaud JP, Harbarth S. The Lancet Infectious Diseases, October 2018, doi: 10.1016/S1473-3099(18)30513-9.

Click here to read the article / PDF

We use cookies to provide you a better experience and understand how our site is being used. To consent to the use of cookies, click ‘Accept’. Learn more about our cookie and privacy policy.